Hedgehog signaling pathway
The Hedgehog signaling pathway is a signaling pathway that transmits information to embryonic cells required for proper development. Different parts of the embryo have different concentrations of hedgehog signaling proteins. The pathway also has roles in the adult. Diseases associated with the malfunction of this pathway include basal cell carcinoma.
The Hedgehog signaling pathway is one of the key regulators of animal development and is present in all bilaterians. The pathway takes its name from its polypeptide ligand, an intercellular signaling molecule called Hedgehog (Hh) found in fruit flies of the genus Drosophila. Hh is one of Drosophila's segment polarity gene products, involved in establishing the basis of the fly body plan. The molecule remains important during later stages of embryogenesis and metamorphosis.
Mammals have three Hedgehog homologues, Desert (DHH), Indian (IHH), and Sonic (SHH), of which Sonic is the best studied. The pathway is equally important during vertebrate embryonic development. In knockout mice lacking components of the pathway, the brain, skeleton, musculature, gastrointestinal tract and lungs fail to develop correctly. Recent studies point to the role of Hedgehog signaling in regulating adult stem cells involved in maintenance and regeneration of adult tissues. The pathway has also been implicated in the development of some cancers. Drugs that specifically target Hedgehog signaling to fight this disease are being actively developed by a number of pharmaceutical companies.
In the 1970s, a fundamental problem in developmental biology was to understand how a relatively simple egg can give rise to a complex segmented body plan. In the late 1970s Christiane Nüsslein-Volhard and Eric Wieschaus isolated mutations in genes that control development of the segmented anterior-posterior body axis of the fly; their "saturation mutagenesis" technique resulted in the discovery of a group of genes involved in the development of body segmentation. In 1995, they shared the Nobel Prize with Edward B. Lewis for their work studying genetic mutations in Drosophila embryogenesis.
The Drosophila hedgehog (hh) gene was identified as one of several genes important for creating the differences between the anterior and posterior parts of individual body segments. The fly hh gene was independently cloned in 1992 by the labs of Jym Mohler, Philip Beachy, and Thomas B. Kornberg. Some hedgehog mutants result in abnormally-shaped embryos that are unusually short and stubby compared to wild type embryos. The function of the hedgehog segment polarity gene has been studied in terms of its influence on the normally polarized distribution of larval cuticular denticles as well as features on adult appendages such as legs and antennae. Rather than the normal pattern of denticles, hedgehog mutant larvae tend to have "solid lawns" of denticles (Figure 1). The appearance of the stubby and "hairy" larvae inspired the name 'hedgehog'.
Insect cells express a full size zinc-finger transcription factor Cubitus interruptus (Ci), which forms a complex with the kinesin- like protein Costal-2 (Cos2) and is localized in the cytoplasm bound to cellular microtubules (Figure 2). The SCF complex targets the 155 kDa full length Ci protein for proteosome-dependent cleavage, which generates a 75 kDa fragment (CiR). CiR builds up in the cell and diffuses into the nucleus, where it acts as a co-repressor for Hh target genes. The steps leading to Ci protein proteolysis include phosphorylation of Ci protein by several protein kinases; PKA, GSK3β and CK1 (Figure 2). The Drosophila protein Slimb is part of an SCF complex that targets proteins for ubiquitylation. Slimb binds to phosphorylated Ci protein.
In the absence of Hh (Figure 3), a cell-surface transmembrane protein called Patched (PTCH) acts to prevent high expression and activity of a 7 membrane spanning receptor called Smoothened (SMO). Patched has sequence similarity to known membrane transport proteins. When extracellular Hh is present (Figure 3), it binds to and inhibits Patched, allowing Smoothened to accumulate and inhibit the proteolytic cleavage of the Ci protein. This process most likely involves the direct interaction of Smoothened and Costal-2 and may involve sequestration of the Ci protein-containing complex to a microdomain where the steps leading to Ci protein proteolysis are disrupted. The mechanism by which Hh binding to Patched leads to increased levels of Smoothened is not clear (Step 1 in Figure 3). Following binding of Hh to Patched, Smoothened levels increase greatly over the level maintained in cells when Patched is not bound to Hh. It has been suggested that phosphorylation of Smoothened plays a role in Hh-dependent regulation of Smoothened levels.
In cells with Hh-activated Patched (Figure 3), the intact Ci protein accumulates in the cell cytoplasm and levels of CiR decrease, allowing transcription of some genes such as decapentaplegic (dpp, a member of the BMP growth factor family). For other Hh-regulated genes, expression requires not only the loss of CiR but also the positive action of uncleaved Ci to act as a transcriptional activator. Costal-2 is normally important for holding Ci protein in the cytoplasm, but interaction of Smoothened with Costal-2 allows some intact Ci protein to go to the nucleus. The Drosophila protein Fused (Fu in Figure 3) is a protein kinase that binds to Costal-2. Fused can inhibit Suppressor of Fused (SUFU), which in turn interacts with Ci to regulate gene transcription in some cell types.
Hedgehog has roles in larval body segment development and in formation of adult appendages. During the formation of body segments in the developing Drosophila embryo, stripes of cells that synthesize the transcription factor Engrailed can also express the cell-to-cell signaling protein Hedgehog (green in Figure 4). Hedgehog is not free to move very far from the cells that make it and so it only activates a thin stripe of cells adjacent to the Engrailed-expressing cells. When acting in this local fashion, hedgehog works as a paracrine factor. Only cells to one side of the Engrailed-expressing cells are competent to respond to Hedgehog following interaction of Hh with the receptor protein Patched (blue in Figure 4).
Cells with Hh-activated Patched receptor synthesize the Wingless protein (red in Figure 4). If a Drosophila embryo is altered so as to produce Hh in all cells, all of the competent cells respond and form a broader band of Wingless-expressing cells in each segment. The wingless gene has an upstream transcription regulatory region that binds the Ci transcription factor in a Hh-dependent fashion resulting in an increase in wingless transcription (interaction 2 in Figure 3) in a stripe of cells adjacent to the stripe of Hh-producing cells.
Wingless protein acts as an extracellular signal and patterns the adjacent rows of cells by activating its cell surface receptor Frizzled. Wingless acts on Engrailed-expressing cells to stabilize the stripes of Engrailed expression. Wingless is a member of the Wnt family of cell-to-cell signaling proteins. The reciprocal signaling by Hedgehog and Wingless stabilizes the boundary between parasegments (Figure 4, top). The effects of Wingless and Hedgehog on other stripes of cells in each segment establishes a positional code that accounts for the distinct anatomical features along the anterior-posterior axis of the segments.
The Wingless protein is called "wingless" because of the phenotype of some wingless fly mutants. Wingless and Hedgehog functioned together during metamorphosis to coordinate wing formation. Hedgehog is expressed in the posterior part of developing Drosophila limbs. Hedgehog also participates in the coordination of eye, brain, gonad, gut and tracheal development. Hedgehog has been implicated in reduced eye development in the amphipod Gammarus minus. Specifically, downregulation of hedgehog results in reduced eyes.
Hedgehog is also involved in segmentation in the annelid worms; because parallel evolution seems unlikely, this suggests a common origin of segmentation between the two phyla. Whilst Hh does not induce the formation of segments, it seems to act to stabilize the segmented fields once they have appeared.
Sonic hedgehog (SHH) is the best studied ligand of the vertebrate pathway. Most of what is known about hedgehog signaling has been established by studying SHH. It is translated as a ~45kDa precursor and undergoes autocatalytic processing (Process "1" on Figure 5) to produce an ~20kDa N-terminal signaling domain (referred to as SHH-N) and a ~25kDa C-terminal domain with no known signaling role. During the cleavage, a cholesterol molecule is added to the carboxyl end of the N-terminal domain, which is involved in trafficking, secretion and receptor interaction of the ligand. SHH can signal in an autocrine fashion, affecting the cells in which it is produced. Secretion and consequent paracrine hedgehog signaling require the participation of Dispatched (DISP) protein (Process "2" on Figure 5).
When SHH reaches its target cell, it binds to the Patched-1 (PTCH1) receptor (Process "3" on Figure 5, the blue molecule, which is mislabelled DISP). In the absence of ligand, PTCH1 inhibits Smoothened (SMO), a downstream protein in the pathway (Process "4"). It has been suggested that SMO is regulated by a small molecule, the cellular localization of which is controlled by PTCH. PTCH1 has homology to Niemann-Pick disease, type C1 (NPC1) that is known to transport lipophilic molecules across a membrane. PTCH1 has a sterol sensing domain (SSD), which has been shown to be essential for suppression of SMO activity. A current theory suggests that PTCH regulates SMO by removing oxysterols from SMO. PTCH acts like a sterol pump and removes oxysterols that have been created by 7-dehydrocholesterol reductase. Upon binding of a Hh protein or a mutation in the SSD of PTCH, the pump is turned off allowing oxysterols to accumulate around SMO.
This accumulation of sterols allows SMO to become active or stay on the membrane for a longer period of time. This hypothesis is supported by the existence of a number of small molecule agonists and antagonists of the pathway that act on SMO. The binding of SHH relieves SMO inhibition, leading to activation of the GLI transcription factors (Process "5"): the activators Gli1 and Gli2 and the repressor Gli3. The sequence of molecular events that connect SMO to GLIs is poorly understood. Activated GLI accumulates in the nucleus (Process "6") and controls the transcription of hedgehog target genes (Process "7"). PTCH1 has recently been reported to repress transcription of hedgehog target genes through a mechanism independent of Smoothened.
In addition to PTCH1, mammals have another hedgehog receptor, PTCH2, whose sequence identity with PTCH1 is 54%. All three mammalian hedgehogs bind both receptors with similar affinity, so PTCH1 and PTCH2 cannot discriminate between the ligands. They do, however, differ in their expression patterns. PTCH2 is expressed at much higher levels in the testis and mediates desert hedgehog signaling there. It appears to have a distinct downstream signaling role from PTCH1. In the absence of ligand binding PTCH2 has a decreased ability to inhibit the activity of SMO. Furthermore, overexpression of PTCH2 does not replace mutated PTCH1 in basal cell carcinoma.
In invertebrates, just as in Drosophila, the binding of Hedgehog to PTCH leads to internalisation and sequestration of the ligand. Consequently in vivo the passage of hedgehog over a receptive field that expresses the receptor leads to attenuation of the signal, an effect called ligand-dependent antagonism (LDA). In contrast to Drosophila, vertebrates possess another level of hedgehog regulation through LDA mediated by Hh-interacting protein 1 (HHIP1). HHIP1 also sequesters hedgehog ligands, but unlike PTCH, it has no effect on the activity of SMO.
Members of the hedgehog family play key roles in a wide variety of developmental processes. One of the best studied examples is the action of Sonic hedgehog during development of the vertebrate limb. The classic experiments of Saunders and Gasseling in 1968 on the development of the chick limb bud formed the basis of the morphogen concept. They showed that identity of the digits in the chick limb was determined by a diffusible factor produced by the zone of polarizing activity (ZPA), a small region of tissue at the posterior margin of the limb. Mammalian development appeared to follow the same pattern. This diffusible factor was later shown to be Sonic hedgehog. However, precisely how SHH determines digit identity remained elusive until recently. The current model, proposed by Harfe et al., states that both the concentration and the time of exposure to SHH determines which digit the tissue will develop into in the mouse embryo (figure 6).
Digits V, IV and part of III arise directly from cells that express SHH during embryogenesis. In these cells SHH signals in an autocrine fashion and these digits develop correctly in the absence of DISP, which is required for extracellular diffusion of the ligand. These digits differ in the length of time that SHH continues to be expressed. The most posterior digit V develops from cells that express the ligand for the longest period of time. Digit IV cells express SHH for a shorter time, and digit III cells shorter still. Digit II develops from cells that are exposed to moderate concentrations of extracellular SHH. Finally, Digit I development does not require SHH. It is, in a sense, the default program of limb bud cells.
Hedgehog signaling remains important in the adult. Sonic hedgehog has been shown to promote the proliferation of adult stem cells from various tissues, including primitive hematopoietic cells, mammary and neural stem cells. Activation of the hedgehog pathway is required for transition of the hair follicle from the resting to the growth phase. This failed due to toxicities found in animal models.
Disruption of hedgehog signaling during embryonic development, through either deleterious mutation or consumption of teratogens by the gestating mother, can lead to severe developmental abnormalities. Holoprosencephaly, the failure of the embryonic prosencephalon to divide to form cerebral hemispheres, occurs with a frequency of about 1 in 8,000 live births and about 1 in 200 spontaneous abortions in humans and is commonly linked to mutations in genes involved in the hedgehog pathway, including SHH and PTCH. Cyclopia, one of the most severe defects of holoprosencephaly, results if the pathway inhibitor cyclopamine is consumed by gestating mammals.
Activation of the hedgehog pathway has been implicated in the development of cancers in various organs, including brain, lung, mammary gland, prostate and skin. Basal cell carcinoma, the most common form of cancerous malignancy, has the closest association with hedgehog signaling. Loss-of-function mutations in Patched and activating mutations in Smoothened have been identified in patients with this disease. Abnormal activation of the pathway probably leads to development of disease through transformation of adult stem cells into cancer stem cells that give rise to the tumor. Cancer researchers hope that specific inhibitors of hedgehog signaling will provide an efficient therapy for a wide range of malignancies.
Targeting the hedgehog pathway
The most common way to target this pathway is modulate SMO. Antagonist and agonist of SMO have already shown to effect the pathway regulation downstream. The most clinically advanced SMO targeting agents are cyclopamine-competitive. Itraconazole (Sporanox) has also been shown to target SMO through a mechanism distinct from cyclopamine and vismodegib. Itraconazole inhibits SMO in the presence of mutations conferring resistance to vismodegib and other cyclopamine-competitive antagonists, like IPI-926 and Novartis' LDE-225. PTCH and Gli3 (5E1) antibodies are also a way to regulate the pathway. A downstream effector and strong transcriptional activator siRNA Gli1 has been used to inhibit cell growth and promote apoptosis. Arsenic trioxide (Trisenox) has also been shown to inhibit hedgehog signaling by interfering with Gli function and transcription.
Activation of the Hedgehog pathway leads to an increase in Snail protein expression and a decrease in E-cadherin and Tight Junctions. Hedgehog signaling also appears to be a crucial regulator of angiogenesis and thus metastasis.
Activation of the Hedgehog pathway leads to an increase in Angiogenic Factors (angiopoietin-1 and angiopoietin-2), Cyclins (cyclin D1 and B1)), anti-apoptotic genes and a decrease in apoptotic genes (Fas).
- Vismodegib -Video Presentation from AACR.org FDA approved (Jan 2012) for basal cell carcinoma.
- Sonidegib, under investigation for numerous cancers
Hedgehog-like genes, 2 Patched homologs and Patched-related genes exist in the worm C. elegans. These genes have been shown to code for proteins that have roles in C. elegans development. The hedgehog-like and Patched-related gene families are very large and function without the need for a Smoothened homolog, suggesting a distinct pattern of selection for cholesterol modification and sensing mechanisms in coelomate and pseudo-coelomate lineages.
Lancelets, which are primitive chordates, possess only one homologue of Drosophila Hh (figure 7). Vertebrates, on the other hand, have several hedgehog ligands that fall within three subgroups - desert, Indian and sonic, each represented by a single mammalian gene. This is probably a consequence of the two genome duplications that occurred early in the vertebrate evolutionary history. Two such events would have produced four homologous genes, one of which must have been lost. Desert hedgehogs are the most closely related to Drosophila Hh. Additional gene duplications occurred within some species such as the zebrafish Danio rerio, which has an additional tiggywinkle hedgehog gene in the sonic group. Various vertebrate lineages have adapted hedgehogs to unique developmental processes. For example, a homologue of the X.laevis banded hedgehog is involved in regeneration of the salamander limb.
shh has undergone accelerated evolution in the primate lineage leading to humans. Dorus et al. hypothesise that this allowed for more complex regulation of the protein and may have played a role in the increase in volume and complexity of the human brain.
The frizzled family of WNT receptors have some sequence similarity to Smoothened. However, G proteins have been difficult to link to the function Smoothened. Smoothened seems to be a functionally divergent member of the G protein coupled receptor super family. Other similarities between the WNT and Hh signaling pathways have been reviewed. Nusse observed that, "a signaling system based on lipid-modified proteins and specific membrane translocators is ancient, and may have been the founder of the Wnt and Hh signaling systems".
It has been suggested that invertebrate and vertebrate signaling downstream from Smoothened has diverged significantly. The role of Suppressor of Fused (SUFU) has been enhanced in vertebrates compared to Drosophila where its role is relatively minor. Costal-2 is particularly important in Drosophila. The protein kinase Fused is a regulator of SUFU in Drosophila, but may not play a role in the Hh pathway of vertebrates. In vertebrates, Hh signaling has been heavily coupled to cilia.
The hedgehog protein appears to have evolved in two sections, the N-terminal domain (hedge) and the C-terminal domain (hog), that only later were spliced together into a single transcriptional unit. The hedge domain contains a sequence called Hint (Hedgehog INTein), which is similar in sequence and function to bacterial and fungal inteins. Choanoflagellates contain a region named hoglet that is similar to the hedgehog C-terminal domain. In addition, molecular phylogenetic analysis revealed that hoglet was more similar to hog than it was to bacterial inteins. Choanoflagellates do not contain any regions similar to the hedge domain, suggesting that hog evolved first. Poriferans have both hedge-like proteins (termed hedgling) and hog-like proteins, but they exist as two completely separate transcriptional units. Cnidarians contain the hedgling and hog genes, but also have a complete hedgehog gene, indicating that hedge and hog were spliced into hedgehog after the last common ancestor of poriferans and cnidarians. Bilaterians do not contain hedgling genes, suggesting that these were lost by deletion before this branch split from the other metazoans.
- Sonic hedgehog, best studied ligand of the vertebrate pathway
- Smoothened, the conserved GPCR component of the pathway
- Netpath – A curated resource of signal transduction pathways in humans
- Inhibitors of Hh signaling
- Kimball's Biology Pages, The Hedgehog Signaling Pathway[self-published source?]
- Ingham, Philip W.; Nakano, Yoshiro; Seger, Claudia (2011). "Mechanisms and functions of Hedgehog signalling across the metazoa". Nature Reviews Genetics 12 (6): 393–406. doi:10.1038/nrg2984. PMID 21502959.
- Nüsslein-Volhard, Christiane; Wieschaus, Eric (1980). "Mutations affecting segment number and polarity in Drosophila". Nature 287 (5785): 795–801. doi:10.1038/287795a0. PMID 6776413.
- 1995 Nobel Prize for discovery of the genetic control of early embryonic development
- Mohler, Jym (December 1988). "Requirements for hedgehog, a Segmental Polarity Gene, in Patterning Larval and Adult Cuticle of Drosophila". Genetics 120 (4): 1061–72. PMC 1203569. PMID 3147217.
- Collins, R. T.; Cohen, SM (2005). "A Genetic Screen in Drosophila for Identifying Novel Components of the Hedgehog Signaling Pathway". Genetics 170 (1): 173–84. doi:10.1534/genetics.104.039420. PMC 1449730. PMID 15744048.
- Lum, L.; Beachy, PA (2004). "The Hedgehog Response Network: Sensors, Switches, and Routers". Science 304 (5678): 1755–9. doi:10.1126/science.1098020. PMID 15205520.
- Chen, W.; Ren, XR; Nelson, CD; Barak, LS; Chen, JK; Beachy, PA; De Sauvage, F; Lefkowitz, RJ (2004). "Activity-Dependent Internalization of Smoothened Mediated by -Arrestin 2 and GRK2". Science 306 (5705): 2257–60. doi:10.1126/science.1104135. PMID 15618519.
- Alcedo, Joy; Zou, Yu; Noll, Markus (2000). "Posttranscriptional Regulation of Smoothened is Part of a Self-Correcting Mechanism in the Hedgehog Signaling System". Molecular Cell 6 (2): 457–65. doi:10.1016/S1097-2765(00)00044-7. PMID 10983991.
- Apionishev, Sergey; Katanayeva, Natalya M.; Marks, Steven A.; Kalderon, Daniel; Tomlinson, Andrew (2004). "Drosophila Smoothened phosphorylation sites essential for Hedgehog signal transduction". Nature Cell Biology 7 (1): 86–92. doi:10.1038/ncb1210. PMID 15592457.
- Ho, K. S.; Suyama, K; Fish, M; Scott, MP (2005). "Differential regulation of Hedgehog target gene transcription by Costal2 and Suppressor of Fused". Development 132 (6): 1401–12. doi:10.1242/dev.01689. PMID 15750186.
- Von Ohlen, T.; Lessing, D; Nusse, R; Hooper, JE (1997). "Hedgehog signaling regulates transcription through cubitus interruptus, a sequence-specific DNA binding protein". Proceedings of the National Academy of Sciences 94 (6): 2404–9. doi:10.1073/pnas.94.6.2404. PMC 20100. PMID 9122207.
- Ingham, P. W.; McMahon, AP (2001). "Hedgehog signaling in animal development: Paradigms and principles". Genes & Development 15 (23): 3059–87. doi:10.1101/gad.938601. PMID 11731473.
- Aspiras, A.C.; Prasad, R.; Fong, D.W.; Carlini, D.B.; Angelini, D.R. (2012). "Parallel reduction in expression of the eye development gene hedgehog in separately derived cave populations of the amphipod Gammarus minus". Journal of Evolutionary Biology 25: 995–1001. doi:10.1111/j.1420-9101.2012.02481.x.
- Dray, N.; Tessmar-Raible, K.; Le Gouar, M.; Vibert, L.; Christodoulou, F.; Schipany, K.; Guillou, A.; Zantke, J.; et al. (2010). "Hedgehog Signaling Regulates Segment Formation in the Annelid Platynereis". Science 329 (5989): 339–42. doi:10.1126/science.1188913. PMC 3182550. PMID 20647470.
- Taipale, J.; Cooper, M. K.; Maiti, T.; Beachy, P. A. (2002). "Patched acts catalytically to suppress the activity of Smoothened". Nature 418 (6900): 892–7. doi:10.1038/nature00989. PMID 12192414.
- Davies, J. P.; Chen, FW; Ioannou, YA (2000). "Transmembrane Molecular Pump Activity of Niemann-Pick C1 Protein". Science 290 (5500): 2295–8. doi:10.1126/science.290.5500.2295. PMID 11125140.
- Strutt, H.; Thomas, C.; Nakano, Y.; Stark, D.; Neave, B.; Taylor, A.M.; Ingham, P.W. (2001). "Mutations in the sterol-sensing domain of Patched suggest a role for vesicular trafficking in Smoothened regulation". Current Biology 11 (8): 608–13. doi:10.1016/S0960-9822(01)00179-8. PMID 11369206.
- Corcoran, R. B.; Scott, MP (2006). "Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells". Proceedings of the National Academy of Sciences 103 (22): 8408–13. doi:10.1073/pnas.0602852103. PMC 1462959. PMID 16707575.
- Shimokawa, Takashi; Rahnama, Fahimeh; Lauth, Matthias; Finta, Csaba; Kogerman, Priit; Teglund, Stephan; Toftgård, Rune; Zaphiropoulos, Peter G. (2006). "Inhibition of GLI1 gene activation by Patched1". Biochemical Journal 394 (Pt 1): 19–26. doi:10.1042/BJ20050941. PMC 1385998. PMID 16229683.
- Carpenter, D.; Stone, DM; Brush, J; Ryan, A; Armanini, M; Frantz, G; Rosenthal, A; De Sauvage, FJ (1998). "Characterization of two patched receptors for the vertebrate hedgehog protein family". Proceedings of the National Academy of Sciences 95 (23): 13630–4. doi:10.1073/pnas.95.23.13630. PMC 24870. PMID 9811851.
- Rahnama, Fahimeh; Toftgård, Rune; Zaphiropoulos, Peter G. (2004). "Distinct roles of PTCH2 splice variants in Hedgehog signalling". Biochemical Journal 378 (2): 325–34. doi:10.1042/BJ20031200. PMC 1223965. PMID 14613484.
- Zaphiropoulos, Peter G.; Undén, Anne Birgitte; Rahnama, Fahimeh; Hollingsworth, Robert E.; Toftgård, Rune (1999). "PTCH2, a Novel Human Patched Gene, Undergoing Alternative Splicing andUp-regulated in Basal Cell Carcinomas". Cancer Research 59 (4): 787–92. PMID 10029063.
- Incardona, J. P.; Lee, J. H.; Robertson, C. P.; Enga, K.; Kapur, R. P.; Roelink, H. (2000). "Receptor-mediated endocytosis of soluble and membrane-tethered Sonic hedgehog by Patched-1". Proceedings of the National Academy of Sciences 97 (22): 12044. doi:10.1073/pnas.220251997.
- Jeong, J.; McMahon, AP (2004). "Growth and pattern of the mammalian neural tube are governed by partially overlapping feedback activities of the hedgehog antagonists patched 1 and Hhip1". Development 132 (1): 143–54. doi:10.1242/dev.01566. PMID 15576403.
- Harfe, Brian D.; Scherz, Paul J.; Nissim, Sahar; Tian, Hua; McMahon, Andrew P.; Tabin, Clifford J. (2004). "Evidence for an Expansion-Based Temporal Shh Gradient in Specifying Vertebrate Digit Identities". Cell 118 (4): 517–28. doi:10.1016/j.cell.2004.07.024. PMID 15315763.
- Bhardwaj, G.; Murdoch, B.; Wu, D.; Baker, D. P.; Williams, K. P.; Chadwick, K.; Ling, L. E.; Karanu, F. N.; Bhatia, M. (2001). "Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation". Nature Immunology 2 (2): 172–80. doi:10.1038/84282. PMID 11175816.
- Liu, S.; Dontu, G; Mantle, ID; Patel, S; Ahn, NS; Jackson, KW; Suri, P; Wicha, MS (2006). "Hedgehog Signaling and Bmi-1 Regulate Self-renewal of Normal and Malignant Human Mammary Stem Cells". Cancer Research 66 (12): 6063–71. doi:10.1158/0008-5472.CAN-06-0054. PMID 16778178.
- Ahn, Sohyun; Joyner, Alexandra L. (2005). "In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog". Nature 437 (7060): 894–7. doi:10.1038/nature03994. PMID 16208373.
- Paladini, Rudolph D.; Saleh, Jacqueline; Qian, Changgeng; Xu, Guang-Xin; Rubin, Lee L. (2005). "Modulation of Hair Growth with Small Molecule Agonists of the Hedgehog Signaling Pathway". Journal of Investigative Dermatology 125 (4): 638–46. doi:10.1111/j.0022-202X.2005.23867.x. PMID 16185261.
- http://phx.corporate-ir.net/phoenix.zhtml?c=123198&p=irol-newsArticle&ID=997941&highlight=[full citation needed]
- Online 'Mendelian Inheritance in Man' (OMIM) Holoprosencephaly -236100
- Keeler, Richard F. (1978). "Cyclopamine and related steroidal alkaloid teratogens: Their occurrence, structural relationship, and biologic effects". Lipids 13 (10): 708–15. doi:10.1007/BF02533750. PMID 723484.
- Epstein, Ervin H.; De Sauvage, Frederic J.; Xie, Jingwu; Murone, Maximilien; Luoh, Shiuh-Ming; Ryan, Anne; Gu, Qimin; Zhang, Chaohui; et al. (1998). "Activating Smoothened mutations in sporadic basal-cell carcinoma". Nature 391 (6662): 90–2. doi:10.1038/34201. PMID 9422511.
- Chen, J. K.; Taipale, J; Young, KE; Maiti, T; Beachy, PA (2002). "Small molecule modulation of Smoothened activity". Proceedings of the National Academy of Sciences 99 (22): 14071–6. doi:10.1073/pnas.182542899. PMC 137838. PMID 12391318.
- Kim, James; Tang, Jean Y.; Gong, Ruoyu; Kim, Jynho; Lee, John J.; Clemons, Karl V.; Chong, Curtis R.; Chang, Kris S.; et al. (2010). "Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth". Cancer Cell 17 (4): 388–99. doi:10.1016/j.ccr.2010.02.027. PMID 20385363.
- Kim, J; Aftab, BT; Tang, JY; Kim, D; Lee, AH; Rezaee, M; Kim, J; Chen, B; King, EM; Borodovsky, A; Riggins, GJ; Epstein Jr, EH; Beachy, PB; Rudin, CM (2013). "Itraconazole and arsenic trioxide inhibit hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists". Cancer Cell 23 (1): 23–34. doi:10.1016/j.ccr.2012.11.017. PMC 3548977. PMID 23291299.
- Nakamura, M; Kubo, M; Yanai, K; Mikami, Y; Ikebe, M; Nagai, S; Yamaguchi, K; Tanaka, M; Katano, M (2007). "Anti-patched-1 antibodies suppress hedgehog signaling pathway and pancreatic cancer proliferation". Anticancer research 27 (6A): 3743–7. PMID 17970037.
- Hunt, Reet; Bragina, Olga; Drews, Monika; Kasak, Lagle; Timmusk, Sirje; Valkna, Andres; Kogerman, Priit; Järvekülg, Lilian (2007). "Generation and Characterization of Mouse Monoclonal Antibody 5E1 Against Human Transcription Factor GLI3". Hybridoma 26 (4): 231–40. doi:10.1089/hyb.2007.0507. PMID 17725385.
- Stecca, Barbara; Mas, Christophe; Altaba, Ariel Ruiz i (2005). "Interference with HH–GLI signaling inhibits prostate cancer". Trends in Molecular Medicine 11 (5): 199–203. doi:10.1016/j.molmed.2005.03.004. PMID 15882606.
- Beauchamp, Elspeth M.; Ringer, Lymor; Bulut, Gülay; Sajwan, Kamal P.; Hall, Michael D.; Lee, Yi-Chien; Peaceman, Daniel; Özdemirli, Metin; et al. (2011). "Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway". Journal of Clinical Investigation 121 (1): 148–60. doi:10.1172/JCI42874. PMC 3007144. PMID 21183792.
- Kim, J.; Lee, J. J.; Kim, J.; Gardner, D.; Beachy, P. A. (2010). "Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector". Proceedings of the National Academy of Sciences 107 (30): 13432–7. doi:10.1073/pnas.1006822107. PMC 2922148. PMID 20624968.
- Li, Xingnan; Deng, Wentao; Nail, Clinton D; Bailey, Sarah K; Kraus, Matthias H; Ruppert, J Michael; Lobo-Ruppert, Susan M (2005). "Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation". Oncogene 25 (4). doi:10.1038/sj.onc.1209077.
- Velcheti, V (2007). "Hedgehog signaling is a potent regulator of angiogenesis in small cell lung cancer". Medical Hypotheses 69 (4): 948–9. doi:10.1016/j.mehy.2007.02.021. PMID 17637503.
- Lee, SW; Moskowitz, MA; Sims, JR (2007). "Sonic hedgehog inversely regulates the expression of angiopoietin-1 and angiopoietin-2 in fibroblasts". International journal of molecular medicine 19 (3): 445–51. doi:10.3892/ijmm.19.3.445. PMID 17273793.
- Adolphe, C.; Hetherington, R; Ellis, T; Wainwright, B (2006). "Patched1 Functions as a Gatekeeper by Promoting Cell Cycle Progression". Cancer Research 66 (4): 2081–8. doi:10.1158/0008-5472.CAN-05-2146. PMID 16489008.
- Athar, M.; Li, C; Tang, X; Chi, S; Zhang, X; Kim, AL; Tyring, SK; Kopelovich, L; et al. (2004). "Inhibition of Smoothened Signaling Prevents Ultraviolet B-Induced Basal Cell Carcinomas through Regulation of Fas Expression and Apoptosis". Cancer Research 64 (20): 7545–52. doi:10.1158/0008-5472.CAN-04-1393. PMID 15492281.
- Clinical trial number NCT00636610 for "A Study of GDC-0449 (Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer" at ClinicalTrials.gov
- Clinical trial number NCT00607724 for "GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors" at ClinicalTrials.gov
- http://app2.capitalreach.com/esp1204/servlet/tc?cn=aacr&c=10165&s=20385&e=9628&&m=1&br=80&audio=false[full citation needed]
- Clinical trial number NCT01108094 for "Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas" at ClinicalTrials.gov
- Zugasti, O.; Rajan, J; Kuwabara, PE (2005). "The function and expansion of the Patched- and Hedgehog-related homologs in C. Elegans". Genome Research 15 (10): 1402–10. doi:10.1101/gr.3935405. PMC 1240083. PMID 16204193.
- Novatchkova, M.; Wildpaner, M.; Schweizer, D.; Eisenhaber, F. (2005). "PhyloDome--visualization of taxonomic distributions of domains occurring in eukaryote protein sequence sets". Nucleic Acids Research 33 (Web Server issue): W121–5. doi:10.1093/nar/gki373. PMC 1160134. PMID 15980439.
- "Genome duplications of early vertebrates as a possible chronicle of the evolutionary history of the neural crest.". 2006: 133–41. doi:10.7150/ijbs.2.133. PMC 1474148. PMID 16763673.
- Stark, David R.; Gates, Phillip B.; Brockes, Jeremy P.; Ferretti, Patrizia (1998). "Hedgehog family member is expressed throughout regenerating and developing limbs". Developmental Dynamics 212 (3): 352–63. doi:10.1002/(SICI)1097-0177(199807)212:3<352::AID-AJA3>3.0.CO;2-G. PMID 9671939.
- Dorus, S.; Anderson, JR; Vallender, EJ; Gilbert, SL; Zhang, L; Chemnick, LG; Ryder, OA; Li, W; Lahn, BT (2006). "Sonic Hedgehog, a key development gene, experienced intensified molecular evolution in primates". Human Molecular Genetics 15 (13): 2031–7. doi:10.1093/hmg/ddl123. PMID 16687440.
- Graul, Richard C.; Sadée, Wolfgang (2001). "Evolutionary relationships among G protein-coupled receptors using a clustered database approach". AAPS PharmSci 3 (2): 25. doi:10.1208/ps030212. PMC 2779559. PMID 11741263.
- Nusse, R. (2003). "Wnts and Hedgehogs: Lipid-modified proteins and similarities in signaling mechanisms at the cell surface". Development 130 (22): 5297–305. doi:10.1242/dev.00821. PMID 14530294.
- Varjosalo, Markku; Li, Song-Ping; Taipale, Jussi (2006). "Divergence of Hedgehog Signal Transduction Mechanism between Drosophila and Mammals". Developmental Cell 10 (2): 177–86. doi:10.1016/j.devcel.2005.12.014. PMID 16459297.
- Chen, M.-H.; Gao, N.; Kawakami, T.; Chuang, P.-T. (2005). "Mice Deficient in the Fused Homolog Do Not Exhibit Phenotypes Indicative of Perturbed Hedgehog Signaling during Embryonic Development". Molecular and Cellular Biology 25 (16): 7042–53. doi:10.1128/MCB.25.16.7042-7053.2005. PMC 1190231. PMID 16055716.
- Huangfu, D.; Anderson, KV (2006). "Signaling from Smo to Ci/Gli: Conservation and divergence of Hedgehog pathways from Drosophila to vertebrates". Development 133 (1): 3–14. doi:10.1242/dev.02169. PMID 16339192.
- Matus, David Q.; Magie, Craig R.; Pang, Kevin; Martindale, Mark Q.; Thomsen, Gerald H. (2008). "The Hedgehog gene family of the cnidarian, Nematostella vectensis, and implications for understanding metazoan Hedgehog pathway evolution". Developmental Biology 313 (2): 501–18. doi:10.1016/j.ydbio.2007.09.032. PMC 2288667. PMID 18068698.
- Adamska, Maja; Matus, David Q.; Adamski, Marcin; Green, Kathryn; Rokhsar, Daniel S.; Martindale, Mark Q.; Degnan, Bernard M. (2007). "The evolutionary origin of hedgehog proteins". Current Biology 17 (19): R836–7. doi:10.1016/j.cub.2007.08.010. PMID 17925209.
- Snell, E. A; Brooke, N. M; Taylor, W. R; Casane, D.; Philippe, H.; Holland, P. W.H (2006). "An unusual choanoflagellate protein released by Hedgehog autocatalytic processing". Proceedings of the Royal Society B: Biological Sciences 273 (1585): 401–7. doi:10.1098/rspb.2005.3263. PMC 1560198. PMID 16615205.
- http://hedgehog.sfsu.edu (Hedgehog Pathway Database)
- http://www.novusbio.com/hedgehogpathway.html (Hedgehog Signaling Pathway Diagram)